Saudi Arabia-based Al Murjan Group has partnered with Mediclinic Middle East, a subsidiary of UK healthcare group Mediclinic International, to construct a new hospital in Jeddah.

The 200-bed facility will be built on 80,000m2 area, with an investment of more than SR1bn ($266mn).

Under the terms of the alliance, Mediclinic Middle East will manage the facility. The company will also support Al Murjan via expertise and advisory services in planning, design and construction of the hospital.

The commissioning of the new hospital, which will be located on King Abdul Aziz Road in the northern part of Jeddah, is expected by the second quarter of 2022.

Al Murjan Group chairman Abdulrahman Khalid bin Mahfouz said: “We believe this will serve as the cornerstone for high-quality health care services in Saudi Arabia, offering state-of-the-art health care facilities, from some of the best practitioners, using best practices and meet international quality standards, and contribute to the Kingdom’s Vision 2030.”

With eight floors, the hospital will provide both inpatient and outpatient services such as general surgery, internal medicine, cardiology, orthopedics, obstetrics and gynecology, pediatrics, emergency, and trauma care.

Al Murjan Group vice-chairman Sultan Khalid bin Mahfouz said that the hospital will create more than 1,000 jobs, along with new opportunities for entrepreneurs in the health care sector.

Mediclinic Middle East CEO David Hadley said: “There is a growing demand for high quality, internationally recognized standards of health care services in Saudi Arabia.

“Mediclinic, with more than 35 years’ experience of delivering health care services across Switzerland, Southern Africa and the UAE, is excited by the opportunity to partner with Al Murjan Group to establish a leading private hospital in Jeddah and further expansion opportunities across Saudi Arabia.”

The first phase of the hospital will be constructed on 18,000m2, noted Zawya news agency.